Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Petitjeans, F; Leroy, S; Pichot, C; Geloen, A; Ghignone, M; Quintin, L

Petitjeans, F; Leroy, S; Pichot, C; Geloen, A; Ghignone, M; Quintin, L.

Afiliação

Petitjeans F; Critical Care, Hôpital d'Instruction des Armées Desgenettes, Lyon, France.
Leroy S; Pediatric Emergency Medicine, Hôpital Avicenne, Paris-Bobigny, France.
Pichot C; Critical Care, Hôpital d'Instruction des Armées Desgenettes, Lyon, France.
Geloen A; Physiology, INSA de Lyon (CARMeN, INSERM U 1060), Lyon-Villeurbanne, France.
Ghignone M; Critical Care, JF Kennedy Hospital North Campus, WPalm Beach, Fl, USA.
Quintin L; Critical Care, Hôpital d'Instruction des Armées Desgenettes, Lyon, France.

Temperature (Austin) ; 5(3): 224-256, 2018.

Article em En | MEDLINE | ID: mdl-30393754

Palavras-chave

acute respiratory distress syndrome; clonidine; dexmedetomidine; fever control; high PEEP; hyperthermia; hypothermia; septic shock; spontaneous breathing; sympathetic system

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Temperature (Austin) Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google